/
roda_attributions.txt
1885 lines (1719 loc) · 114 KB
/
roda_attributions.txt
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
** Open Targets; version 2020_06 --
https://www.targetvalidation.org/downloads/data
Apache License
Version 2.0, January 2004
http://www.apache.org/licenses/ TERMS AND CONDITIONS FOR USE, REPRODUCTION, AND
DISTRIBUTION
1. Definitions.
"License" shall mean the terms and conditions for use, reproduction, and
distribution as defined by Sections 1 through 9 of this document.
"Licensor" shall mean the copyright owner or entity authorized by the
copyright owner that is granting the License.
"Legal Entity" shall mean the union of the acting entity and all other
entities that control, are controlled by, or are under common control
with that entity. For the purposes of this definition, "control" means
(i) the power, direct or indirect, to cause the direction or management
of such entity, whether by contract or otherwise, or (ii) ownership of
fifty percent (50%) or more of the outstanding shares, or (iii)
beneficial ownership of such entity.
"You" (or "Your") shall mean an individual or Legal Entity exercising
permissions granted by this License.
"Source" form shall mean the preferred form for making modifications,
including but not limited to software source code, documentation source,
and configuration files.
"Object" form shall mean any form resulting from mechanical
transformation or translation of a Source form, including but not limited
to compiled object code, generated documentation, and conversions to
other media types.
"Work" shall mean the work of authorship, whether in Source or Object
form, made available under the License, as indicated by a copyright
notice that is included in or attached to the work (an example is
provided in the Appendix below).
"Derivative Works" shall mean any work, whether in Source or Object form,
that is based on (or derived from) the Work and for which the editorial
revisions, annotations, elaborations, or other modifications represent,
as a whole, an original work of authorship. For the purposes of this
License, Derivative Works shall not include works that remain separable
from, or merely link (or bind by name) to the interfaces of, the Work and
Derivative Works thereof.
"Contribution" shall mean any work of authorship, including the original
version of the Work and any modifications or additions to that Work or
Derivative Works thereof, that is intentionally submitted to Licensor for
inclusion in the Work by the copyright owner or by an individual or Legal
Entity authorized to submit on behalf of the copyright owner. For the
purposes of this definition, "submitted" means any form of electronic,
verbal, or written communication sent to the Licensor or its
representatives, including but not limited to communication on electronic
mailing lists, source code control systems, and issue tracking systems
that are managed by, or on behalf of, the Licensor for the purpose of
discussing and improving the Work, but excluding communication that is
conspicuously marked or otherwise designated in writing by the copyright
owner as "Not a Contribution."
"Contributor" shall mean Licensor and any individual or Legal Entity on
behalf of whom a Contribution has been received by Licensor and
subsequently incorporated within the Work.
2. Grant of Copyright License. Subject to the terms and conditions of this
License, each Contributor hereby grants to You a perpetual, worldwide,
non-exclusive, no-charge, royalty-free, irrevocable copyright license to
reproduce, prepare Derivative Works of, publicly display, publicly perform,
sublicense, and distribute the Work and such Derivative Works in Source or
Object form.
3. Grant of Patent License. Subject to the terms and conditions of this
License, each Contributor hereby grants to You a perpetual, worldwide,
non-exclusive, no-charge, royalty-free, irrevocable (except as stated in
this section) patent license to make, have made, use, offer to sell, sell,
import, and otherwise transfer the Work, where such license applies only to
those patent claims licensable by such Contributor that are necessarily
infringed by their Contribution(s) alone or by combination of their
Contribution(s) with the Work to which such Contribution(s) was submitted.
If You institute patent litigation against any entity (including a
cross-claim or counterclaim in a lawsuit) alleging that the Work or a
Contribution incorporated within the Work constitutes direct or contributory
patent infringement, then any patent licenses granted to You under this
License for that Work shall terminate as of the date such litigation is
filed.
4. Redistribution. You may reproduce and distribute copies of the Work or
Derivative Works thereof in any medium, with or without modifications, and
in Source or Object form, provided that You meet the following conditions:
(a) You must give any other recipients of the Work or Derivative Works a
copy of this License; and
(b) You must cause any modified files to carry prominent notices stating
that You changed the files; and
(c) You must retain, in the Source form of any Derivative Works that You
distribute, all copyright, patent, trademark, and attribution notices
from the Source form of the Work, excluding those notices that do not
pertain to any part of the Derivative Works; and
(d) If the Work includes a "NOTICE" text file as part of its
distribution, then any Derivative Works that You distribute must include
a readable copy of the attribution notices contained within such NOTICE
file, excluding those notices that do not pertain to any part of the
Derivative Works, in at least one of the following places: within a
NOTICE text file distributed as part of the Derivative Works; within the
Source form or documentation, if provided along with the Derivative
Works; or, within a display generated by the Derivative Works, if and
wherever such third-party notices normally appear. The contents of the
NOTICE file are for informational purposes only and do not modify the
License. You may add Your own attribution notices within Derivative Works
that You distribute, alongside or as an addendum to the NOTICE text from
the Work, provided that such additional attribution notices cannot be
construed as modifying the License.
You may add Your own copyright statement to Your modifications and may
provide additional or different license terms and conditions for use,
reproduction, or distribution of Your modifications, or for any such
Derivative Works as a whole, provided Your use, reproduction, and
distribution of the Work otherwise complies with the conditions stated in
this License.
5. Submission of Contributions. Unless You explicitly state otherwise, any
Contribution intentionally submitted for inclusion in the Work by You to the
Licensor shall be under the terms and conditions of this License, without
any additional terms or conditions. Notwithstanding the above, nothing
herein shall supersede or modify the terms of any separate license agreement
you may have executed with Licensor regarding such Contributions.
6. Trademarks. This License does not grant permission to use the trade
names, trademarks, service marks, or product names of the Licensor, except
as required for reasonable and customary use in describing the origin of the
Work and reproducing the content of the NOTICE file.
7. Disclaimer of Warranty. Unless required by applicable law or agreed to in
writing, Licensor provides the Work (and each Contributor provides its
Contributions) on an "AS IS" BASIS, WITHOUT WARRANTIES OR CONDITIONS OF ANY
KIND, either express or implied, including, without limitation, any
warranties or conditions of TITLE, NON-INFRINGEMENT, MERCHANTABILITY, or
FITNESS FOR A PARTICULAR PURPOSE. You are solely responsible for determining
the appropriateness of using or redistributing the Work and assume any risks
associated with Your exercise of permissions under this License.
8. Limitation of Liability. In no event and under no legal theory, whether
in tort (including negligence), contract, or otherwise, unless required by
applicable law (such as deliberate and grossly negligent acts) or agreed to
in writing, shall any Contributor be liable to You for damages, including
any direct, indirect, special, incidental, or consequential damages of any
character arising as a result of this License or out of the use or inability
to use the Work (including but not limited to damages for loss of goodwill,
work stoppage, computer failure or malfunction, or any and all other
commercial damages or losses), even if such Contributor has been advised of
the possibility of such damages.
9. Accepting Warranty or Additional Liability. While redistributing the Work
or Derivative Works thereof, You may choose to offer, and charge a fee for,
acceptance of support, warranty, indemnity, or other liability obligations
and/or rights consistent with this License. However, in accepting such
obligations, You may act only on Your own behalf and on Your sole
responsibility, not on behalf of any other Contributor, and only if You
agree to indemnify, defend, and hold each Contributor harmless for any
liability incurred by, or claims asserted against, such Contributor by
reason of your accepting any such warranty or additional liability. END OF
TERMS AND CONDITIONS
APPENDIX: How to apply the Apache License to your work.
To apply the Apache License to your work, attach the following boilerplate
notice, with the fields enclosed by brackets "[]" replaced with your own
identifying information. (Don't include the brackets!) The text should be
enclosed in the appropriate comment syntax for the file format. We also
recommend that a file or class name and description of purpose be included on
the same "printed page" as the copyright notice for easier identification
within third-party archives.
Copyright [yyyy] [name of copyright owner]
Licensed under the Apache License, Version 2.0 (the "License");
you may not use this file except in compliance with the License.
You may obtain a copy of the License at
http://www.apache.org/licenses/LICENSE-2.0
Unless required by applicable law or agreed to in writing, software
distributed under the License is distributed on an "AS IS" BASIS,
WITHOUT WARRANTIES OR CONDITIONS OF ANY KIND, either express or implied.
See the License for the specific language governing permissions and
limitations under the License.
* For Open Targets see also this required NOTICE:
Copyright 2014-2018 Bristol Myers Squibb, EMBL - European Bioinformatics
Institute, GlaxoSmithKline, Takeda Pharmaceutical Company, Sanofi S.A., and
Wellcome Sanger Institute.
------
** BindingDB; version 2019_11 --
https://www.bindingdb.org/bind/chemsearch/marvin/SDFdownload.jsp?all_download=yes
Citation: Michael K. Gilson, Tiqing Liu, Michael Baitaluk, George Nicola, Linda
Hwang, Jenny Chong, BindingDB in 2015: A public database for medicinal
chemistry, computational chemistry and systems pharmacology, Nucleic Acids
Research, Volume 44, Issue D1, 4 January 2016, Pages D1045–D1053,
https://doi.org/10.1093/nar/gkv1072
License
THE WORK (AS DEFINED BELOW) IS PROVIDED UNDER THE TERMS OF THIS CREATIVE
COMMONS PUBLIC LICENSE ("CCPL" OR "LICENSE"). THE WORK IS PROTECTED BY
COPYRIGHT AND/OR OTHER APPLICABLE LAW. ANY USE OF THE WORK OTHER THAN AS
AUTHORIZED UNDER THIS LICENSE OR COPYRIGHT LAW IS PROHIBITED.
BY EXERCISING ANY RIGHTS TO THE WORK PROVIDED HERE, YOU ACCEPT AND AGREE TO BE
BOUND BY THE TERMS OF THIS LICENSE. TO THE EXTENT THIS LICENSE MAY BE
CONSIDERED TO BE A CONTRACT, THE LICENSOR GRANTS YOU THE RIGHTS CONTAINED HERE
IN CONSIDERATION OF YOUR ACCEPTANCE OF SUCH TERMS AND CONDITIONS.
1. Definitions
"Collective Work" means a work, such as a periodical issue, anthology or
encyclopedia, in which the Work in its entirety in unmodified form, along with
one or more other contributions, constituting separate and independent works in
themselves, are assembled into a collective whole. A work that constitutes a
Collective Work will not be considered a Derivative Work (as defined below) for
the purposes of this License.
"Derivative Work" means a work based upon the Work or upon the Work and other
pre-existing works, such as a translation, musical arrangement, dramatization,
fictionalization, motion picture version, sound recording, art reproduction,
abridgment, condensation, or any other form in which the Work may be recast,
transformed, or adapted, except that a work that constitutes a Collective Work
will not be considered a Derivative Work for the purpose of this License. For
the avoidance of doubt, where the Work is a musical composition or sound
recording, the synchronization of the Work in timed-relation with a moving
image ("synching") will be considered a Derivative Work for the purpose of this
License.
"Licensor" means the individual, individuals, entity or entities that offers
the Work under the terms of this License.
"Original Author" means the individual, individuals, entity or entities who
created the Work.
"Work" means the copyrightable work of authorship offered under the terms of
this License.
"You" means an individual or entity exercising rights under this License who
has not previously violated the terms of this License with respect to the Work,
or who has received express permission from the Licensor to exercise rights
under this License despite a previous violation.
2. Fair Use Rights. Nothing in this license is intended to reduce, limit, or
restrict any rights arising from fair use, first sale or other limitations on
the exclusive rights of the copyright owner under copyright law or other
applicable laws.
3. License Grant. Subject to the terms and conditions of this License, Licensor
hereby grants You a worldwide, royalty-free, non-exclusive, perpetual (for the
duration of the applicable copyright) license to exercise the rights in the
Work as stated below:
to reproduce the Work, to incorporate the Work into one or more Collective
Works, and to reproduce the Work as incorporated in the Collective Works;
to create and reproduce Derivative Works provided that any such Derivative
Work, including any translation in any medium, takes reasonable steps to
clearly label, demarcate or otherwise identify that changes were made to the
original Work. For example, a translation could be marked "The original work
was translated from English to Spanish," or a modification could indicate "The
original work has been modified.";;
to distribute copies or phonorecords of, display publicly, perform publicly,
and perform publicly by means of a digital audio transmission the Work
including as incorporated in Collective Works;
to distribute copies or phonorecords of, display publicly, perform publicly,
and perform publicly by means of a digital audio transmission Derivative Works.
For the avoidance of doubt, where the Work is a musical composition:
Performance Royalties Under Blanket Licenses. Licensor waives the exclusive
right to collect, whether individually or, in the event that Licensor is a
member of a performance rights society (e.g. ASCAP, BMI, SESAC), via that
society, royalties for the public performance or public digital performance
(e.g. webcast) of the Work.
Mechanical Rights and Statutory Royalties. Licensor waives the exclusive right
to collect, whether individually or via a music rights agency or designated
agent (e.g. Harry Fox Agency), royalties for any phonorecord You create from
the Work ("cover version") and distribute, subject to the compulsory license
created by 17 USC Section 115 of the US Copyright Act (or the equivalent in
other jurisdictions).
Webcasting Rights and Statutory Royalties. For the avoidance of doubt, where
the Work is a sound recording, Licensor waives the exclusive right to collect,
whether individually or via a performance-rights society (e.g. SoundExchange),
royalties for the public digital performance (e.g. webcast) of the Work,
subject to the compulsory license created by 17 USC Section 114 of the US
Copyright Act (or the equivalent in other jurisdictions).
The above rights may be exercised in all media and formats whether now known or
hereafter devised. The above rights include the right to make such
modifications as are technically necessary to exercise the rights in other
media and formats. All rights not expressly granted by Licensor are hereby
reserved.
4. Restrictions. The license granted in Section 3 above is expressly made
subject to and limited by the following restrictions:
You may distribute, publicly display, publicly perform, or publicly digitally
perform the Work only under the terms of this License, and You must include a
copy of, or the Uniform Resource Identifier for, this License with every copy
or phonorecord of the Work You distribute, publicly display, publicly perform,
or publicly digitally perform. You may not offer or impose any terms on the
Work that restrict the terms of this License or the ability of a recipient of
the Work to exercise the rights granted to that recipient under the terms of
the License. You may not sublicense the Work. You must keep intact all notices
that refer to this License and to the disclaimer of warranties. When You
distribute, publicly display, publicly perform, or publicly digitally perform
the Work, You may not impose any technological measures on the Work that
restrict the ability of a recipient of the Work from You to exercise the rights
granted to that recipient under the terms of the License. This Section 4(a)
applies to the Work as incorporated in a Collective Work, but this does not
require the Collective Work apart from the Work itself to be made subject to
the terms of this License. If You create a Collective Work, upon notice from
any Licensor You must, to the extent practicable, remove from the Collective
Work any credit as required by Section 4(b), as requested. If You create a
Derivative Work, upon notice from any Licensor You must, to the extent
practicable, remove from the Derivative Work any credit as required by Section
4(b), as requested.
If You distribute, publicly display, publicly perform, or publicly digitally
perform the Work (as defined in Section 1 above) or any Derivative Works (as
defined in Section 1 above) or Collective Works (as defined in Section 1
above), You must, unless a request has been made pursuant to Section 4(a), keep
intact all copyright notices for the Work and provide, reasonable to the medium
or means You are utilizing: (i) the name of the Original Author (or pseudonym,
if applicable) if supplied, and/or (ii) if the Original Author and/or Licensor
designate another party or parties (e.g. a sponsor institute, publishing
entity, journal) for attribution ("Attribution Parties") in Licensor's
copyright notice, terms of service or by other reasonable means, the name of
such party or parties; the title of the Work if supplied; to the extent
reasonably practicable, the Uniform Resource Identifier, if any, that Licensor
specifies to be associated with the Work, unless such URI does not refer to the
copyright notice or licensing information for the Work; and, consistent with
Section 3(b) in the case of a Derivative Work, a credit identifying the use of
the Work in the Derivative Work (e.g., "French translation of the Work by
Original Author," or "Screenplay based on original Work by Original Author").
The credit required by this Section 4(b) may be implemented in any reasonable
manner; provided, however, that in the case of a Derivative Work or Collective
Work, at a minimum such credit will appear, if a credit for all contributing
authors of the Derivative Work or Collective Work appears, then as part of
these credits and in a manner at least as prominent as the credits for the
other contributing authors. For the avoidance of doubt, You may only use the
credit required by this Section for the purpose of attribution in the manner
set out above and, by exercising Your rights under this License, You may not
implicitly or explicitly assert or imply any connection with, sponsorship or
endorsement by the Original Author, Licensor and/or Attribution Parties, as
appropriate, of You or Your use of the Work, without the separate, express
prior written permission of the Original Author, Licensor and/or Attribution
Parties.
5. Representations, Warranties and Disclaimer
UNLESS OTHERWISE MUTUALLY AGREED TO BY THE PARTIES IN WRITING, LICENSOR OFFERS
THE WORK AS-IS AND ONLY TO THE EXTENT OF ANY RIGHTS HELD IN THE LICENSED WORK
BY THE LICENSOR. THE LICENSOR MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY
KIND CONCERNING THE WORK, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING,
WITHOUT LIMITATION, WARRANTIES OF TITLE, MARKETABILITY, MERCHANTIBILITY,
FITNESS FOR A PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR
OTHER DEFECTS, ACCURACY, OR THE PRESENCE OF ABSENCE OF ERRORS, WHETHER OR NOT
DISCOVERABLE. SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED
WARRANTIES, SO SUCH EXCLUSION MAY NOT APPLY TO YOU.
6. Limitation on Liability. EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW, IN
NO EVENT WILL LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY FOR ANY SPECIAL,
INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES ARISING OUT OF THIS
LICENSE OR THE USE OF THE WORK, EVEN IF LICENSOR HAS BEEN ADVISED OF THE
POSSIBILITY OF SUCH DAMAGES.
7. Termination
This License and the rights granted hereunder will terminate automatically upon
any breach by You of the terms of this License. Individuals or entities who
have received Derivative Works (as defined in Section 1 above) or Collective
Works (as defined in Section 1 above) from You under this License, however,
will not have their licenses terminated provided such individuals or entities
remain in full compliance with those licenses. Sections 1, 2, 5, 6, 7, and 8
will survive any termination of this License.
Subject to the above terms and conditions, the license granted here is
perpetual (for the duration of the applicable copyright in the Work).
Notwithstanding the above, Licensor reserves the right to release the Work
under different license terms or to stop distributing the Work at any time;
provided, however that any such election will not serve to withdraw this
License (or any other license that has been, or is required to be, granted
under the terms of this License), and this License will continue in full force
and effect unless terminated as stated above.
8. Miscellaneous
Each time You distribute or publicly digitally perform the Work (as defined in
Section 1 above) or a Collective Work (as defined in Section 1 above), the
Licensor offers to the recipient a license to the Work on the same terms and
conditions as the license granted to You under this License.
Each time You distribute or publicly digitally perform a Derivative Work,
Licensor offers to the recipient a license to the original Work on the same
terms and conditions as the license granted to You under this License.
If any provision of this License is invalid or unenforceable under applicable
law, it shall not affect the validity or enforceability of the remainder of the
terms of this License, and without further action by the parties to this
agreement, such provision shall be reformed to the minimum extent necessary to
make such provision valid and enforceable.
No term or provision of this License shall be deemed waived and no breach
consented to unless such waiver or consent shall be in writing and signed by
the party to be charged with such waiver or consent.
This License constitutes the entire agreement between the parties with respect
to the Work licensed here. There are no understandings, agreements or
representations with respect to the Work not specified here. Licensor shall not
be bound by any additional provisions that may appear in any communication from
You. This License may not be modified without the mutual written agreement of
the Licensor and You.
------
** ChEMBL; version 2.7 --
https://chembl.gitbook.io/chembl-interface-documentation/downloads
Copyright © EMBL-EBI 2018 | EMBL-EBI is part of the European Molecular Biology
Laboratory
License
THE WORK (AS DEFINED BELOW) IS PROVIDED UNDER THE TERMS OF THIS CREATIVE
COMMONS PUBLIC LICENSE ("CCPL" OR "LICENSE"). THE WORK IS PROTECTED BY
COPYRIGHT AND/OR OTHER APPLICABLE LAW. ANY USE OF THE WORK OTHER THAN AS
AUTHORIZED UNDER THIS LICENSE OR COPYRIGHT LAW IS PROHIBITED.
BY EXERCISING ANY RIGHTS TO THE WORK PROVIDED HERE, YOU ACCEPT AND AGREE TO BE
BOUND BY THE TERMS OF THIS LICENSE. TO THE EXTENT THIS LICENSE MAY BE
CONSIDERED TO BE A CONTRACT, THE LICENSOR GRANTS YOU THE RIGHTS CONTAINED HERE
IN CONSIDERATION OF YOUR ACCEPTANCE OF SUCH TERMS AND CONDITIONS.
1. Definitions
"Adaptation" means a work based upon the Work, or upon the Work and other
pre-existing works, such as a translation, adaptation, derivative work,
arrangement of music or other alterations of a literary or artistic work, or
phonogram or performance and includes cinematographic adaptations or any other
form in which the Work may be recast, transformed, or adapted including in any
form recognizably derived from the original, except that a work that
constitutes a Collection will not be considered an Adaptation for the purpose
of this License. For the avoidance of doubt, where the Work is a musical work,
performance or phonogram, the synchronization of the Work in timed-relation
with a moving image ("synching") will be considered an Adaptation for the
purpose of this License.
"Collection" means a collection of literary or artistic works, such as
encyclopedias and anthologies, or performances, phonograms or broadcasts, or
other works or subject matter other than works listed in Section 1(f) below,
which, by reason of the selection and arrangement of their contents, constitute
intellectual creations, in which the Work is included in its entirety in
unmodified form along with one or more other contributions, each constituting
separate and independent works in themselves, which together are assembled into
a collective whole. A work that constitutes a Collection will not be considered
an Adaptation (as defined below) for the purposes of this License.
"Creative Commons Compatible License" means a license that is listed at
https://creativecommons.org/compatiblelicenses that has been approved by
Creative Commons as being essentially equivalent to this License, including, at
a minimum, because that license: (i) contains terms that have the same purpose,
meaning and effect as the License Elements of this License; and, (ii)
explicitly permits the relicensing of adaptations of works made available under
that license under this License or a Creative Commons jurisdiction license with
the same License Elements as this License.
"Distribute" means to make available to the public the original and copies of
the Work or Adaptation, as appropriate, through sale or other transfer of
ownership.
"License Elements" means the following high-level license attributes as
selected by Licensor and indicated in the title of this License: Attribution,
ShareAlike.
"Licensor" means the individual, individuals, entity or entities that offer(s)
the Work under the terms of this License.
"Original Author" means, in the case of a literary or artistic work, the
individual, individuals, entity or entities who created the Work or if no
individual or entity can be identified, the publisher; and in addition (i) in
the case of a performance the actors, singers, musicians, dancers, and other
persons who act, sing, deliver, declaim, play in, interpret or otherwise
perform literary or artistic works or expressions of folklore; (ii) in the case
of a phonogram the producer being the person or legal entity who first fixes
the sounds of a performance or other sounds; and, (iii) in the case of
broadcasts, the organization that transmits the broadcast.
"Work" means the literary and/or artistic work offered under the terms of this
License including without limitation any production in the literary, scientific
and artistic domain, whatever may be the mode or form of its expression
including digital form, such as a book, pamphlet and other writing; a lecture,
address, sermon or other work of the same nature; a dramatic or
dramatico-musical work; a choreographic work or entertainment in dumb show; a
musical composition with or without words; a cinematographic work to which are
assimilated works expressed by a process analogous to cinematography; a work of
drawing, painting, architecture, sculpture, engraving or lithography; a
photographic work to which are assimilated works expressed by a process
analogous to photography; a work of applied art; an illustration, map, plan,
sketch or three-dimensional work relative to geography, topography,
architecture or science; a performance; a broadcast; a phonogram; a compilation
of data to the extent it is protected as a copyrightable work; or a work
performed by a variety or circus performer to the extent it is not otherwise
considered a literary or artistic work.
"You" means an individual or entity exercising rights under this License who
has not previously violated the terms of this License with respect to the Work,
or who has received express permission from the Licensor to exercise rights
under this License despite a previous violation.
"Publicly Perform" means to perform public recitations of the Work and to
communicate to the public those public recitations, by any means or process,
including by wire or wireless means or public digital performances; to make
available to the public Works in such a way that members of the public may
access these Works from a place and at a place individually chosen by them; to
perform the Work to the public by any means or process and the communication to
the public of the performances of the Work, including by public digital
performance; to broadcast and rebroadcast the Work by any means including
signs, sounds or images.
"Reproduce" means to make copies of the Work by any means including without
limitation by sound or visual recordings and the right of fixation and
reproducing fixations of the Work, including storage of a protected performance
or phonogram in digital form or other electronic medium.
2. Fair Dealing Rights. Nothing in this License is intended to reduce, limit,
or restrict any uses free from copyright or rights arising from limitations or
exceptions that are provided for in connection with the copyright protection
under copyright law or other applicable laws.
3. License Grant. Subject to the terms and conditions of this License, Licensor
hereby grants You a worldwide, royalty-free, non-exclusive, perpetual (for the
duration of the applicable copyright) license to exercise the rights in the
Work as stated below:
to Reproduce the Work, to incorporate the Work into one or more Collections,
and to Reproduce the Work as incorporated in the Collections;
to create and Reproduce Adaptations provided that any such Adaptation,
including any translation in any medium, takes reasonable steps to clearly
label, demarcate or otherwise identify that changes were made to the original
Work. For example, a translation could be marked "The original work was
translated from English to Spanish," or a modification could indicate "The
original work has been modified.";
to Distribute and Publicly Perform the Work including as incorporated in
Collections; and,
to Distribute and Publicly Perform Adaptations.
For the avoidance of doubt:
Non-waivable Compulsory License Schemes. In those jurisdictions in which the
right to collect royalties through any statutory or compulsory licensing scheme
cannot be waived, the Licensor reserves the exclusive right to collect such
royalties for any exercise by You of the rights granted under this License;
Waivable Compulsory License Schemes. In those jurisdictions in which the right
to collect royalties through any statutory or compulsory licensing scheme can
be waived, the Licensor waives the exclusive right to collect such royalties
for any exercise by You of the rights granted under this License; and,
Voluntary License Schemes. The Licensor waives the right to collect royalties,
whether individually or, in the event that the Licensor is a member of a
collecting society that administers voluntary licensing schemes, via that
society, from any exercise by You of the rights granted under this License.
The above rights may be exercised in all media and formats whether now known or
hereafter devised. The above rights include the right to make such
modifications as are technically necessary to exercise the rights in other
media and formats. Subject to Section 8(f), all rights not expressly granted by
Licensor are hereby reserved.
4. Restrictions. The license granted in Section 3 above is expressly made
subject to and limited by the following restrictions:
You may Distribute or Publicly Perform the Work only under the terms of this
License. You must include a copy of, or the Uniform Resource Identifier (URI)
for, this License with every copy of the Work You Distribute or Publicly
Perform. You may not offer or impose any terms on the Work that restrict the
terms of this License or the ability of the recipient of the Work to exercise
the rights granted to that recipient under the terms of the License. You may
not sublicense the Work. You must keep intact all notices that refer to this
License and to the disclaimer of warranties with every copy of the Work You
Distribute or Publicly Perform. When You Distribute or Publicly Perform the
Work, You may not impose any effective technological measures on the Work that
restrict the ability of a recipient of the Work from You to exercise the rights
granted to that recipient under the terms of the License. This Section 4(a)
applies to the Work as incorporated in a Collection, but this does not require
the Collection apart from the Work itself to be made subject to the terms of
this License. If You create a Collection, upon notice from any Licensor You
must, to the extent practicable, remove from the Collection any credit as
required by Section 4(c), as requested. If You create an Adaptation, upon
notice from any Licensor You must, to the extent practicable, remove from the
Adaptation any credit as required by Section 4(c), as requested.
You may Distribute or Publicly Perform an Adaptation only under the terms of:
(i) this License; (ii) a later version of this License with the same License
Elements as this License; (iii) a Creative Commons jurisdiction license (either
this or a later license version) that contains the same License Elements as
this License (e.g., Attribution-ShareAlike 3.0 US)); (iv) a Creative Commons
Compatible License. If you license the Adaptation under one of the licenses
mentioned in (iv), you must comply with the terms of that license. If you
license the Adaptation under the terms of any of the licenses mentioned in (i),
(ii) or (iii) (the "Applicable License"), you must comply with the terms of the
Applicable License generally and the following provisions: (I) You must include
a copy of, or the URI for, the Applicable License with every copy of each
Adaptation You Distribute or Publicly Perform; (II) You may not offer or impose
any terms on the Adaptation that restrict the terms of the Applicable License
or the ability of the recipient of the Adaptation to exercise the rights
granted to that recipient under the terms of the Applicable License; (III) You
must keep intact all notices that refer to the Applicable License and to the
disclaimer of warranties with every copy of the Work as included in the
Adaptation You Distribute or Publicly Perform; (IV) when You Distribute or
Publicly Perform the Adaptation, You may not impose any effective technological
measures on the Adaptation that restrict the ability of a recipient of the
Adaptation from You to exercise the rights granted to that recipient under the
terms of the Applicable License. This Section 4(b) applies to the Adaptation as
incorporated in a Collection, but this does not require the Collection apart
from the Adaptation itself to be made subject to the terms of the Applicable
License.
If You Distribute, or Publicly Perform the Work or any Adaptations or
Collections, You must, unless a request has been made pursuant to Section 4(a),
keep intact all copyright notices for the Work and provide, reasonable to the
medium or means You are utilizing: (i) the name of the Original Author (or
pseudonym, if applicable) if supplied, and/or if the Original Author and/or
Licensor designate another party or parties (e.g., a sponsor institute,
publishing entity, journal) for attribution ("Attribution Parties") in
Licensor's copyright notice, terms of service or by other reasonable means, the
name of such party or parties; (ii) the title of the Work if supplied; (iii) to
the extent reasonably practicable, the URI, if any, that Licensor specifies to
be associated with the Work, unless such URI does not refer to the copyright
notice or licensing information for the Work; and (iv) , consistent with
Ssection 3(b), in the case of an Adaptation, a credit identifying the use of
the Work in the Adaptation (e.g., "French translation of the Work by Original
Author," or "Screenplay based on original Work by Original Author"). The credit
required by this Section 4(c) may be implemented in any reasonable manner;
provided, however, that in the case of a Adaptation or Collection, at a minimum
such credit will appear, if a credit for all contributing authors of the
Adaptation or Collection appears, then as part of these credits and in a manner
at least as prominent as the credits for the other contributing authors. For
the avoidance of doubt, You may only use the credit required by this Section
for the purpose of attribution in the manner set out above and, by exercising
Your rights under this License, You may not implicitly or explicitly assert or
imply any connection with, sponsorship or endorsement by the Original Author,
Licensor and/or Attribution Parties, as appropriate, of You or Your use of the
Work, without the separate, express prior written permission of the Original
Author, Licensor and/or Attribution Parties.
Except as otherwise agreed in writing by the Licensor or as may be otherwise
permitted by applicable law, if You Reproduce, Distribute or Publicly Perform
the Work either by itself or as part of any Adaptations or Collections, You
must not distort, mutilate, modify or take other derogatory action in relation
to the Work which would be prejudicial to the Original Author's honor or
reputation. Licensor agrees that in those jurisdictions (e.g. Japan), in which
any exercise of the right granted in Section 3(b) of this License (the right to
make Adaptations) would be deemed to be a distortion, mutilation, modification
or other derogatory action prejudicial to the Original Author's honor and
reputation, the Licensor will waive or not assert, as appropriate, this
Section, to the fullest extent permitted by the applicable national law, to
enable You to reasonably exercise Your right under Section 3(b) of this License
(right to make Adaptations) but not otherwise.
5. Representations, Warranties and Disclaimer
UNLESS OTHERWISE MUTUALLY AGREED TO BY THE PARTIES IN WRITING, LICENSOR OFFERS
THE WORK AS-IS AND MAKES NO REPRESENTATIONS OR WARRANTIES OF ANY KIND
CONCERNING THE WORK, EXPRESS, IMPLIED, STATUTORY OR OTHERWISE, INCLUDING,
WITHOUT LIMITATION, WARRANTIES OF TITLE, MERCHANTIBILITY, FITNESS FOR A
PARTICULAR PURPOSE, NONINFRINGEMENT, OR THE ABSENCE OF LATENT OR OTHER DEFECTS,
ACCURACY, OR THE PRESENCE OF ABSENCE OF ERRORS, WHETHER OR NOT DISCOVERABLE.
SOME JURISDICTIONS DO NOT ALLOW THE EXCLUSION OF IMPLIED WARRANTIES, SO SUCH
EXCLUSION MAY NOT APPLY TO YOU.
6. Limitation on Liability. EXCEPT TO THE EXTENT REQUIRED BY APPLICABLE LAW, IN
NO EVENT WILL LICENSOR BE LIABLE TO YOU ON ANY LEGAL THEORY FOR ANY SPECIAL,
INCIDENTAL, CONSEQUENTIAL, PUNITIVE OR EXEMPLARY DAMAGES ARISING OUT OF THIS
LICENSE OR THE USE OF THE WORK, EVEN IF LICENSOR HAS BEEN ADVISED OF THE
POSSIBILITY OF SUCH DAMAGES.
7. Termination
This License and the rights granted hereunder will terminate automatically upon
any breach by You of the terms of this License. Individuals or entities who
have received Adaptations or Collections from You under this License, however,
will not have their licenses terminated provided such individuals or entities
remain in full compliance with those licenses. Sections 1, 2, 5, 6, 7, and 8
will survive any termination of this License.
Subject to the above terms and conditions, the license granted here is
perpetual (for the duration of the applicable copyright in the Work).
Notwithstanding the above, Licensor reserves the right to release the Work
under different license terms or to stop distributing the Work at any time;
provided, however that any such election will not serve to withdraw this
License (or any other license that has been, or is required to be, granted
under the terms of this License), and this License will continue in full force
and effect unless terminated as stated above.
8. Miscellaneous
Each time You Distribute or Publicly Perform the Work or a Collection, the
Licensor offers to the recipient a license to the Work on the same terms and
conditions as the license granted to You under this License.
Each time You Distribute or Publicly Perform an Adaptation, Licensor offers to
the recipient a license to the original Work on the same terms and conditions
as the license granted to You under this License.
If any provision of this License is invalid or unenforceable under applicable
law, it shall not affect the validity or enforceability of the remainder of the
terms of this License, and without further action by the parties to this
agreement, such provision shall be reformed to the minimum extent necessary to
make such provision valid and enforceable.
No term or provision of this License shall be deemed waived and no breach
consented to unless such waiver or consent shall be in writing and signed by
the party to be charged with such waiver or consent.
This License constitutes the entire agreement between the parties with respect
to the Work licensed here. There are no understandings, agreements or
representations with respect to the Work not specified here. Licensor shall not
be bound by any additional provisions that may appear in any communication from
You. This License may not be modified without the mutual written agreement of
the Licensor and You.
The rights granted under, and the subject matter referenced, in this License
were drafted utilizing the terminology of the Berne Convention for the
Protection of Literary and Artistic Works (as amended on September 28, 1979),
the Rome Convention of 1961, the WIPO Copyright Treaty of 1996, the WIPO
Performances and Phonograms Treaty of 1996 and the Universal Copyright
Convention (as revised on July 24, 1971). These rights and subject matter take
effect in the relevant jurisdiction in which the License terms are sought to be
enforced according to the corresponding provisions of the implementation of
those treaty provisions in the applicable national law. If the standard suite
of rights granted under applicable copyright law includes additional rights not
granted under this License, such additional rights are deemed to be included in
the License; this License is not intended to restrict the license of any rights
under applicable law.
------
** Genome Tissue Expression Database; version v8 --
https://www.gtexportal.org/home/datasets
The Genotype-Tissue Expression (GTEx) Project was supported by the Common Fund
of the Office of the Director of the National Institutes of Health, and by NCI,
NHGRI, NHLBI, NIDA, NIMH, and NINDS. The data used for the analyses described
in this manuscript were obtained from: [insert, where appropriate] the GTEx
Portal on 08/19/2020.
NIH Genomic Data Sharing Policy
Notice Number: NOT-OD-14-124
Key Dates
Release Date: August 27, 2014
Related Announcements
NOT-OD-17-110
NOT-HG-15-038
NOT-OD-15-086
NOT-OD-15-083
NOT-OD-15-027
NOT-OD-14-111
NOT-OD-13-119
NOT-OD-12-136
NOT-HG-10-006
NOT-OD-08-013
NOT-OD-07-088
NOT-OD-07-088
NOT-MH-19-033
NOT-HG-20-011
Issued by
National Institutes of Health (NIH)
Purpose
Summary
The National Institutes of Health (NIH) announces the final Genomic Data
Sharing (GDS) Policy that promotes sharing, for research purposes, of
large-scale human and non-human genomic1 data generated from NIH-funded
research. A summary of public comments on the draft GDS Policy and NIH’s
responses are also provided.
Introduction
NIH announces the final Genomic Data Sharing (GDS) Policy, which sets forth
expectations that ensure the broad and responsible sharing of genomic research
data. Sharing research data supports the NIH mission and is essential to
facilitate the translation of research results into knowledge, products, and
procedures that improve human health. NIH has longstanding policies to make a
broad range of research data, in addition to genomic data, publicly available
in a timely manner from the research activities that it funds.2,3,4,5,6
NIH published the Draft NIH Genomic Data Sharing Policy Request for Public
Comments in the Federal Register on September 20, 2013,7 and the NIH Guide for
Grants and Contracts on September 27, 2013,8 for a 60-day public comment period
that ended November 20, 2013. NIH also used websites, listservs, and social
media to disseminate the request for comments. On November 6, 2013, during the
comment period, NIH held a public webinar on the draft GDS Policy that was
attended by nearly 200 people and included a question and answer session.9
NIH received a total of 107 public comments on the draft GDS Policy. Comments
were submitted by individuals, organizations, and entities affiliated with
academic institutions, professional and scientific societies, disease and
patient advocacy groups, research organizations, industry and commercial
organizations, tribal organizations, state public health agencies, and private
clinical practices. The public comments have been posted on the NIH GDS
website.10 Comments were supportive of the principles of sharing data to
advance research. However, there were a number of questions and concerns, and
calls for clarification about specific aspects of the draft Policy. A summary
of comments, organized by corresponding sections of the GDS Policy, is provided
below.
Scope and Applicability
Several commenters stated that the draft Policy was unclear with regard to the
types of research to which the Policy would apply. Some commenters suggested
that the technology used in a research study (i.e., array-based or
high-throughput genomic technologies) should not be the focus in determining
applicability of the Policy. They suggested instead that the information gained
from the research should determine the applicability of the Policy. Many other
commenters expressed the concern that the Policy was overly broad and would
lead to the submission of large quantities of data with low utility for other
investigators. Several other commenters suggested that the scope of the Policy
was not broad enough. Additionally, some commenters were uncertain about
whether the Policy would apply to research funded by multiple sources.
NIH has revised the Scope and Applicability section to help clarify the types
of research to which the Policy is intended to apply, and the reference to
specific technologies has been dropped. The list of examples of the types of
research projects that are within the Policy’s scope, which appeared in
Appendix A of the draft GDS Policy (now referred to as “Supplemental
Information to the NIH Genomic Data Sharing Policy”11), has been revised and
expanded, and examples of research that are not within the scope have been
added as well. Also, the final GDS Policy now explicitly states that smaller
studies (e.g., sequencing the genomes of fewer than 100 human research
participants) are generally not subject to this Policy. Smaller studies,
however, may be subject to other NIH data sharing policies (e.g., the National
Institute of Allergy and Infectious Diseases Data Sharing and Release
Guidelines12) or program requirements. In addition, definitions of key terms
used in the Policy (e.g., aggregate data) have been included and other terms
have been clarified.
The statement of scope remains intentionally general enough to accommodate the
evolving nature of genomic technologies and the broad range of research that
generates genomic data. It also allows for the possibility that individual NIH
Institutes or Centers (IC) may choose on a case-by-case basis to apply the
Policy to projects generating data on a smaller scale depending on the state of
the science, the needs of the research community, and the programmatic
priorities of the IC. The Policy applies to research funded in part or in total
by NIH if NIH funding supports the generation of the genomic data.
Investigators with questions about whether the Policy applies to their current
or proposed research should consult the relevant Program Official or Program
Officer or the IC’s Genomic Program Administrator (GPA). Names and contact
information for GPAs are available through the NIH GDS website.13
Some commenters expressed concern about the financial burden on investigators
and institutions of validating and sharing large volumes of genomic data and
the possibility that resources spent to support data sharing would redirect
funds away from research. While the resources needed to support data sharing
are not trivial, NIH maintains that the investments are warranted by the
significant discoveries made possible through the secondary use of the data. In
addition, NIH is taking steps to evaluate and monitor the impact of data
sharing costs on the conduct of research, both programmatically through the Big
Data to Knowledge Initiative14 and organizationally through the creation of the
Scientific Data Council, which will advise the agency on issues related to data
science.15
Data Sharing Plans
Some commenters pointed out that the Policy was not clear enough about the
conditions under which NIH would grant an exception to the submission of
genomic data to NIH. Some also suggested that NIH should allow limited sharing
of human genomic data when the original consent or national, tribal, or state
laws do not permit broad sharing.
While NIH encourages investigators to seek consent for broad sharing, and some
ICs may establish program priorities that expect studies proposed for funding
to include consent for broad sharing, exceptions may be made. The final Policy
clarifies that exceptions may be requested in cases where the submission of
genomic data would not meet the criteria for the Institutional Certification.
Some commenters expressed concern that it would be difficult to estimate the
resources required to support data sharing plans before a study is completed.
Others asked for additional guidance on resources that should be requested to
support the data sharing plan. Several commenters suggested that NIH should
allow certain elements of the data sharing plan, such as the Institutional
Certification and associated documentation, to be submitted along with other
“Just-in-Time” information. For multi-year awards, one commenter suggested that
the data sharing plans should be periodically reviewed for consistency with
contemporary ethical standards. Another suggested that data sharing plans
should be made public.
Under the GDS Policy, investigators are expected to outline in the budget
section of their funding application the resources they will need to prepare
the data for submission to appropriate repositories. NIH will provide
additional guidance on these resources, as necessary. The final Policy
clarifies that only a basic genomic data sharing plan, in the Resource Sharing
Plan section of grant applications, needs to be submitted with the funding
application and that a more detailed plan should be provided prior to award.
The Institutional Certification also should be provided prior to award, along
with any other Just-in-Time information. Guidance on genomic data sharing plans
is available on the NIH GDS website.16 Data sharing plans will undergo periodic
review through annual progress reports or other appropriate scientific project
reviews. Further consideration will be given to the suggestion that data
sharing plans should be made public.
Non-human and Model Organism Genomic Data
The draft GDS Policy proposed timelines for data submission and data release
(i.e., when data should be made available for sharing with other
investigators). For non-human data, the draft Policy proposed that data should
be submitted and made available for sharing no later than the date of initial
publication, with the acknowledgement that the submission and release of data
for certain projects may be expected earlier, mirroring data sharing
expectations that have been in place under other policies.4 Some commenters
suggested that the data submission expectations for non-human data were
unclear. One commenter suggested that NIH should consider a more rapid timeline
than the date of first publication for releasing model organism data, while
other comments supported the specified data release timeline. Other commenters
were concerned that the specified timeline was too short.
The final GDS Policy does not change the timeline for the submission and
release of non-human and model organism data. The timeline is based on the need
to promote broad data sharing while also accommodating the investigators
generating the data, who often must make a significant effort to prepare the
data for sharing. The Policy points out that an NIH IC may choose to shorten
the timeline for data submission and release for certain projects and expects
investigators to work with NIH Program or Project Officials for specific
guidance on the timelines and milestones for their projects.
There was broad support for the Policy’s flexibility of allowing non-human and
model organism data to be deposited in any widely used data repository. One
commenter requested that a link or reference to non-NIH-designated repositories
be included in the Policy. Further information about NIH-designated
repositories, including examples of such repositories, is available on the GDS
website,17 and additional information about non-NIH-designated data
repositories will be incorporated in outreach and training materials for NIH
staff and investigators and made available on the GDS website. NIH has
clarified the final Policy to state that data types that were previously
submitted to widely used repositories (e.g., gene expression data to the Gene
Expression Omnibus or Array Express) should continue as before, while data
types not previously submitted may go to these or other widely used
repositories as agreed to by the funding IC.
Human Genomic Data
The Supplemental Information to the NIH GDS Policy10 establishes timelines for
the submission and subsequent release of data for access by secondary
investigators based on the level of processing that the data have undergone. A
number of commenters expressed concern about these timelines, suggesting that
they were too short and could limit an investigator’s ability to perform
adequate quality control and publish results within the provided timeline. Many
commenters proposed that the timeline for data release be extended to 12 or 18
months or be the date of publication, whichever comes first. Others were
concerned that the timelines were too long and that they should reflect the
longstanding principle of rapid data release as articulated in the Bermuda and
Ft. Lauderdale agreements.5 Some commenters were concerned that the elimination
of the embargo period, (i.e., the period between when a study is released for
secondary research and when the submitting investigator first publishes on the
findings of the study) would adversely affect the goal of rapid data release.
One commenter was concerned that data would be released before investigators
could discuss consequential findings with participants.
NIH has modified the Supplemental Information to clarify that the 6-month
deferral for the release of Level 2 and Level 3 human genomic data does not
start until the data have been cleaned and submission to NIH has been
initiated, which is typically about three months after the data have been
generated. Because there will be significant variation in research projects
generating Level 2 and Level 3 human genomic data, the timeline for submission
is project-specific and will be determined in each case by the funding NIH IC
through consultation with the investigator, and the Supplemental Information
has been clarified accordingly. Under the GWAS Policy,6 a publication embargo
period was used as a way of making data more rapidly available. In exchange for
immediate data access, secondary users were not permitted to publish or present
research findings until 12 months after the data were released. NIH did not
adopt this approach for the GDS Policy because in practice, the publication
embargo dates were difficult for secondary users to track, especially for
datasets that had multiple embargo periods for certain types of data, raising
the risk of unintentional embargo violations. Regarding the concern that human
genomic data will be made available before investigators can notify
participants of consequential findings, such data would be considered Level 4
data and would not be expected to be released before publication, which NIH
believes will provide sufficient time to discuss consequential findings with
participants.
Many commenters called for the Policy to include technical data standards for
the submission of human genomic data, such as platform information, controlled
vocabulary, normalization algorithms, data quality standards, and metadata
standards. NIH agrees with the importance of developing and using standards for
genomic data and is aware that there are numerous initiatives underway to
develop and promote such standards.18 NIH has revised the Supplemental
Information by adding a section on resources for data standards. It provides
references to instructions for data submission to specific NIH-designated data
repositories, which include data standards. Additional resources for data
standards will be incorporated in the Supplemental Information as they are
developed and become appropriate for broad use.
Several commenters asked for a definition of an NIH-designated data repository
and for guidance on determining which non-NIH repositories are acceptable as
well as examples of such repositories. Commenters also expressed interest in
additional details regarding the use of Trusted Partners, which are third-party
partnerships established through a contract mechanism, to provide
infrastructure needs for data storage and/or tools that are useful for genomic
data analyses. A definition of an NIH-designated repository is now included in
the final Policy. Additionally, further information about non-NIH-designated
repositories that accept human genomic data will be made available on the GDS
website and incorporated in outreach and training materials for NIH staff and
NIH-funded investigators. Additional information about Trusted Partners,
including the standards required for trusted partnerships, is also available on
the NIH GDS website.16
Regarding informed consent, the GDS Policy expects investigators generating
genomic data to seek consent from participants for future research uses and the
broadest possible sharing. A number of commenters were concerned that
participants would not agree to consent for broad sharing and that enrollment
in research studies may decline, potentially biasing studies if certain
populations were less likely to consent to broad use of their data. Some
commenters also raised a concern about the competitiveness of an application
that proposed to obtain consent for more limited sharing of data. Several
commenters suggested that NIH permit alternative forms of informed consent
other than broad consent, such as dynamic consent or tiered consent.
NIH recognizes that consent for future research uses and broad sharing may not
be appropriate or obtainable in all circumstances. ICs may continue to accept
data from studies with consents that stipulate limitations on future uses and
sharing, and NIH will maintain the data access system that enables more limited
sharing and secondary use. With regard to the competitiveness of grant
applications that do not propose to utilize consent for broad sharing, this
Policy does not propose that applications be assessed on this point during the
merit review, but investigators are nonetheless expected to seek consent for
broad sharing to the greatest extent possible. The breadth of the sharing
permitted by the consent may be taken into consideration during program
priority review by the ICs. Regarding the alternative forms of consent, the